All News #Library
Generics
Difgen Pharma & Apotex Get FDA Nod For Generic Nintedanib
09 Apr 2026 //
PR NEWSWIRE
FDA Approves DifGen`s Generic Mesalamine ER (250mg/500mg)
11 Mar 2026 //
PR NEWSWIRE
Difgen Pharma Secures FDA Approval for Fluorometholone Eye Drops
13 Feb 2026 //
PR NEWSWIRE

Market Place
Sourcing Support